QLT Shows Off Its Assets In Hopes Of Attracting A Suitor
This article was originally published in The Pink Sheet Daily
Executive Summary
The Canadian biotech has put itself on the block after a year of changes that have transformed the company from a commercial-stage entity with pipeline assets to a one-drug tax play.